Trial Profile
Single Center, Single Arm, Open Clinical Study to Access Safety and Initial Efficacy of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Meplazumab (Primary) ; Methylprednisolone
- Indications COVID 2019 infections; Pneumonia
- Focus Therapeutic Use
- 07 Apr 2021 Status changed from recruiting to completed.
- 05 May 2020 New trial record